Myomo (MYO) Total Debt (QoQ) (2017 - 2025)
Myomo (MYO) Total Debt (QoQ) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.39 Bn | 180.09 Bn | 6.27 Bn |
| 2 | Stryker | 132.22 Bn | 129.34 Bn | 3.81 Bn |
| 3 | Medtronic | 111.49 Bn | 102.27 Bn | 6.41 Bn |
| 4 | Boston Scientific | 69.01 Bn | 67.56 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.48 Bn | 44.81 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.75 Bn | 26.47 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.98 Bn | 27.40 Bn | - |
| 9 | Koninklijke Philips | 24.29 Bn | 21.25 Bn | 2.01 Bn |
| 10 | Myomo | 41.21 Mn | 22.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 365.18% |
| Sep 30, 2025 | -21.74% |
| Jun 30, 2020 | -94.54% |
| Mar 31, 2020 | -46.19% |
| Dec 31, 2017 | -14.43% |
| Sep 30, 2017 | 0.00% |